In addition, we assessed the activity of the transcription factors STAT1, NF-κB, and IRF-1, which are thought to be responsible for the induction of IDO expression in response to the treatment of HNSCC cells by IFNγ. This evidence concerns the gene IRF1 and head and neck squamous cell carcinoma.